StemCyte International, Ltd. (TPEX:4178)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
24.50
-0.70 (-2.78%)
At close: Sep 19, 2025

StemCyte International Revenue

StemCyte International had revenue of 197.31M TWD in the half year ending June 30, 2025, with 10.24% growth. This brings the company's revenue in the last twelve months to 398.60M, up 9.15% year-over-year. In the year 2024, StemCyte International had annual revenue of 382.69M with 5.49% growth.

Revenue (ttm)
398.60M
Revenue Growth
+9.15%
P/S Ratio
11.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.71B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024382.69M19.91M5.49%
Dec 31, 2023362.78M15.09M4.34%
Dec 31, 2022347.69M-509.38M-59.43%
Dec 31, 2013857.07M124.33M16.97%
Dec 31, 2012732.74M205.09M38.87%
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition